Regulatory AZ, Amgen will pilot FDA’s real-time clinical trial plan PharmaphorumThe FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.Read full story pharminent April 29, 2026 (Last updated: April 29, 2026) Pharmaphorum The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: AstraZeneca faces uphill battle at upcoming adcomm in face of FDA questionsNext: Pfizer settles with generic drugmakers to protect blockbuster drug until 2031 Related Stories Regulatory Outlook Therapeutics Secures FDA Approval for LYTENAVA pharminent July 31, 2026 Regulatory Outlook finally claims FDA approval for AMD drug pharminent July 27, 2026 Regulatory Outlook Therapeutics wins FDA approval for Lytenava in wet AMD pharminent July 27, 2026
